> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Dynavax Hepatitis B Vaccine
- URL: https://www.fdaweb.com/panel-to-discuss-dynavax-hepatitis-b-vaccine/
- Published: 2016-08-30T12:00:00.000Z
- Updated: 2026-09-14T21:27:59.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136655

*Federal Register* Notice: FDA will hold a meeting of the Vaccines and Related Biological Products Advisory Committee11/16, from 8:30 a.m. to 2:30 p.m. at the FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. The committee will meet in open session to discuss and make recommendations on the safety and efficacy of a hepatitis B vaccine manufactured by Dynavax.Contact **Sujata Vijh** or **Rosanna Harvey**, (240) 402-7107, sujata.vijh@fda.hhs.gov and (240) 402-8072, rosanna.harvey@fda.hhs.gov. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-08-30/pdf/2016-20763.pdf?ref=fdaweb.com)